RADNOR, Pa., Nov. 30, 2018 (GLOBE NEWSWIRE) -- Kaskela Law LLC is investigating Melinta Therapeutics, Inc. ("Melinta" or the "Company") MLNT on behalf of stockholders.
The investigation seeks to determine whether members of Melinta's board of directors breached their fiduciary duties to the Company and its stockholders in connection with recent corporate actions, and whether Melinta investors have been harmed as a result of such actions.
Melinta stockholders are encouraged to immediately contact Kaskela Law LLC (D. Seamus Kaskela, Esq.) at (888) 715 – 1740, or online at http://kaskelalaw.com/case/melinta-therapeutics-inc/, to discuss this investigation and their legal rights and options.
Kaskela Law LLC exclusively represents investors in securities fraud, corporate governance, and other stockholder actions. For additional information about Kaskela Law LLC please visit www.kaskelalaw.com. This notice may constitute attorney advertising in certain jurisdictions.
CONTACT:
KASKELA LAW LLC
D. Seamus Kaskela, Esq.
201 King of Prussia Road
Suite 650
Radnor, PA 19087
(484) 258 – 1585
(888) 715 – 1740
skaskela@kaskelalaw.com
www.kaskelalaw.com
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
